Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix
about
Optimal management of prostate cancer with lethal biology--state-of-the-art local therapyHistological outcomes after focal high-intensity focused ultrasound and cryotherapyComparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis.Adjuvant medical therapy for prostate cancer.Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.Multimodal approaches to high-risk prostate cancer.Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.Current status of radical prostatectomy for high-risk prostate cancer.What has to happen before we report radical prostatectomy outcomes of individual surgeons to the public?Clinical management and burden of prostate cancer: a Markov Monte Carlo model.Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancerSurgery for high-risk localized prostate cancer.Management of high-risk localized prostate cancer.Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancer.Nonautophagic cytoplasmic vacuolation death induction in human PC-3M prostate cancer by curcumin through reactive oxygen species -mediated endoplasmic reticulum stressThe biology and treatment of oligometastatic cancer.Locally advanced prostate cancer: a population-based study of treatment patternsHigh-risk prostate cancer-classification and therapy.Treatment of localized prostate cancer in elderly patients.Optimizing the management of high-risk, localized prostate cancerPrimary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis.Prostate cancer-specific survival differences in patients treated by radical prostatectomy versus curative radiotherapy.Oncologic Outcome of Radical Prostatectomy as Monotherapy for Men with High-risk Prostate Cancer.Divorcing diagnosis from treatment: contemporary management of low-risk prostate cancer.High-risk prostate cancer: is androgen deprivation monotherapy still appropriate?A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons.Animal toxicity of hairpin pyrrole-imidazole polyamides varies with the turn unit.Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: results of a population-based, propensity score-matched analysis.Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation.An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011.Evaluation of biochemical recurrence in patients with high-risk prostate cancer treated with radical prostatectomy and radiotherapy plus androgen deprivation therapy.Refining the American Urological Association and American Society for Radiation Oncology guideline for adjuvant radiotherapy after radical prostatectomy using the pathologic Gleason score.Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.Very-high-risk localized prostate cancer: definition and outcomes.Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer.Systematic review and meta-analysis of the survival outcomes of first-line treatment options in high-risk prostate cancer.High-risk prostate cancer: the role of radical prostatectomy for local therapy.The role of surgery in high-risk localised prostate cancer.
P2860
Q26801188-E065342E-3412-40FF-8E1F-39CE45D80E98Q26820469-42C63844-AAF9-402D-AC86-F25DB05EA379Q33626084-A7C2C3EB-E1B0-4952-B002-418AC4886273Q33758771-595EEBB4-905A-4996-92BD-9B04AF171A47Q34013761-1CCEDFA8-1D94-4B00-AE79-10D476600CF5Q34111597-09C7EC91-4604-4E98-85AF-89E797DE765DQ34288796-066A1638-5B8F-4A4C-A3FA-58C9C591B588Q34346841-FE3D046E-9FC9-4DA8-8124-EB167602CE5FQ34561141-48B968FF-5263-49AA-8C7E-2E4E65931600Q34634410-D8118DAA-595A-43DE-B3BE-27990BDEEE4FQ35115736-C84E7B1C-FF50-434C-9E5C-B9B08D8C58DFQ35220192-D3538C97-6A06-495E-83C6-5FC74A2B0AEFQ35503645-B412A3EC-39C4-4992-8D2E-D63509DDDFEBQ35605945-5AC8C385-C4D5-4386-9E21-4DE08CFBE04EQ35651345-15AE71EF-FAA1-42CD-B2F8-3CEEE2BCB0E3Q35832153-224F5BC8-1FE6-4C9D-B197-0C1373C71F85Q35850867-DEE80DC5-5422-4AE9-9267-F1B6CF8DFC0FQ35869811-84A944B9-AFAB-496C-920F-7D19F6579875Q35912658-D5FC99DD-3EAE-4AE2-A830-23591BFD2428Q36492451-A12FBDB2-76D8-479B-AE45-166AB8B0299DQ36653022-4D7DD10D-F921-425E-B30F-DD233BC8CCACQ36889443-023E5257-3166-4973-AC32-B97BD278EE7EQ37014814-6188D666-1CAD-44B3-8B56-B2B06C03996EQ37025434-76FA9BAF-FF9E-42A1-9047-321F01513C39Q37037832-976C8E92-0D25-4680-B76D-9858766610DBQ37139332-21B1B97D-8CE8-490D-B200-2918C5241555Q37210876-497124F2-3A65-4020-A0D4-37DF487776D2Q37214143-7EE28B5A-16C8-4A29-8612-9483E348BBADQ37302853-93BFFB64-4BEF-4AD9-8DE0-AE859AD8DBEDQ37342181-DE530121-630F-4EE3-8160-869FD6FD16CBQ37421914-1570EF9C-9D04-471D-B643-EF7171C13989Q37485340-2BA4E8B7-9872-4082-A615-31AE50AA52FAQ37581405-AF43C76B-35F0-4594-83FB-74F527DDA723Q37605565-566B9054-A5A6-4B4D-8948-6B65803AD8F6Q37623723-2708AC95-46D2-47B1-A5EB-06A9FD87CD1FQ37636973-75C8DB9C-2E62-4112-9725-010E667E216DQ37689256-4F68E876-0FEC-410A-BA42-0BA674DD8642Q37736313-8AE5553E-5866-448C-BD2A-277458D7B0ECQ37861198-881F130A-7EB1-46F1-B676-31CAE2082CE8Q37939464-65301C0A-5F2A-4F01-AE01-44BF8DCF7068
P2860
Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metastasis after radical prost ...... cohorts adjusted for case mix
@en
Metastasis after radical prost ...... cohorts adjusted for case mix.
@nl
type
label
Metastasis after radical prost ...... cohorts adjusted for case mix
@en
Metastasis after radical prost ...... cohorts adjusted for case mix.
@nl
prefLabel
Metastasis after radical prost ...... cohorts adjusted for case mix
@en
Metastasis after radical prost ...... cohorts adjusted for case mix.
@nl
P2093
P2860
P356
P1476
Metastasis after radical prost ...... cohorts adjusted for case mix
@en
P2093
Angel M Cronin
James A Eastham
Peter T Scardino
Yoshiya Yamada
Zhigang Zhang
P2860
P304
P356
10.1200/JCO.2009.22.2265
P407
P577
2010-02-16T00:00:00Z